The use of big data remains a relatively new concept across the pharmaceutical industry, according to a new study by Cutting Edge Information, which provides research and consulting for the pharmaceutical, biotechnology and medical devices industries.

Just less than half of the top 10 pharmaceutical companies report having dedicated big data teams in place, according to the report, “Pharmaceutical Big Data Insights: Harnessing Real-Time Data to Drive Decision-Making and Innovation.”

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access